$37.9 million for a wearable that must prove its clinical role
MIT’s four-year PYTHIA programme targets continuous biomarker measurement. Its development plan runs from sensors and power supply to validation and clinical testing.
THE LATEST FROM NEXORA
Latest stories.
The latest published briefings from our four editorial desks.
409 people, 17 deaths: reading the mobile-clinic trial
HPTN 094 found no clear improvement in its primary medication-use measures. A secondary mortality result supports further investigation into how mobile clinical services are delivered.
How five currency moves changed a €50,000 invoice basket
We rebuilt five fixed foreign-currency bills from ECB data. An equal €10,000 starting value exposes where the euro helped a purchasing budget and where costs increased.
A grant, a guideline and a trial require different evidence
A wearable research award, a manufacturing guideline and a randomized service trial support different decisions. Our comparison traces the evidence each step requires.
Chip factories need an audit trail for AI decisions
NVIDIA’s semiconductor software connects simulation, learned physics and agents. A deployment checklist follows the handoff from a model’s answer to an engineer’s decision.
Try this workload before replacing an 8GB Windows PC
Microsoft describes memory and responsiveness changes for 8GB machines. A repeatable comparison of everyday work can turn that announcement into a practical replacement decision.
Who owns a city’s AI decision?
NVIDIA’s municipal case studies span resident enquiries, camera analysis and planning. Shared infrastructure brings procurement decisions about permissions, ownership and exit plans.
FDA updates its quality framework for cell and gene therapies
The November 2 guidance covers potency assurance from development through commercial production, including material controls, manufacturing and tests used before batch release.